Manufacturer record
Suyassh Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Suyassh Pharmaceuticals (Gujarat) was declared Not of Standard Quality in February 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: 2201, HITOP 5 ml Eye Drops (Proparacaine Hydrochloride Opthalmic Solution USP 0.5% w/v) (exp May 2023). CDL Kolkata (CDSCO lab) found it not of standard quality: Assay. Listed in the February 2023 alert.
Records by type
1 record linked to Suyassh Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| HITOP 5 ml Eye Drops (Proparacaine Hydrochloride Opthalmic Solution USP 0.5% w/v) | Batch 2201Mfg Jun 2022 · Exp May 2023 | AssayAssay | CDL KolkataCDSCO lab | Feb 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.